Ulla Hald Buhl

​

Ulla has more than 25 years of national and international experience in biotech, and she is a serial entrepreneur as a Founder of 3 companies as well as having key roles in multiple IPO's and running 3 listed companies in Denmark and Sweden.

​

Ulla is driven by collaborating with great and inspiring teams in the development of innovative drugs for patients in need. She is know to work focused and goal-oriented as well as highly dedicated in doing so in a high-performance culture. 

​

Ulla has built up considerable experience in developing strategies for value creation and also implementing core structures to develop and execute on these strategies. In addition, she has played a key role of 2 marketing approvals of oncology drugs from the American and European Health authorities (FDA&EMA).
 

In her C-level roles Ulla has been responsible for a cross-disciplinary and international team in CMC; R&D: biomarker development & lab, clinical drug development including collaboration with multiple CROs for optimal operations. In addition to these roles, Ulla has earned experience as a BoD member in listed and private in both Danish and US companies.